TDI-201

N/A

Report date: 2025/01/26 15:15:17
NME

Base Information

Drug NameTDI-201
Drug Alias NameTDI-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 inhibitors
TargetsEukaryotic Translation Initiation Factor 2 Alpha Kinase 3
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesALS Therapy Development Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesALS Therapy Development Foundation Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A